Skip to main content

Table 2 Comparison of the HBeAg serological conversion rates between the dyslipidemia and normolipidemic groups at different treatment times (number of subjects, %)

From: Effects of dyslipidemia on E antigen seroconversion of patients with chronic hepatitis B treated by nucleoside (acid) analogs

Groups

Number of Subjects

HBeAg Serological Conversion Rate

1st year

2nd year

3rd year

4th year

5th year

Dyslipidemia Group

68

7 (10.3)

9 (13.2)

12 (17.6)

15 (22.1)

19 (27.9)

Normolipidemic Group

111

13 (11.7)

18 (16.2)

20 (18.0)

37 (33.3)

48 (43.2)

Test value

 

0.085

0.293

0.004

2.601

4.216

Р

 

0.770

0.589

0.950

0.107

0.040*

  1. *comparison between the dyslipidemia and normolipidemic groups P < 0.05